Industry Leaders’ Fireside Chat: Allogeneic Therapies Take on Europe

Time: 8:45 am
day: Day One


  • Reviewing clinical and preclinical trials in European allogeneic cell therapies to highlight developmental benefits
  • Touching on the unique challenges of the European field, including market access, regulatory and capacity difficulties, to reveal the practical and strategic considerations for successful development
  • Celebrating European allogeneic advances to encourage further expansion of the field